Borosil Scientific's Q1 Profit Slumps 84% Sequentially Despite Higher Sales
The labware maker's Q1 profit fell sharply from the previous quarter, though it remained profitable year-on-year after a loss.
Borosil Scientific reported an 11.2% rise in Q1 revenue year-on-year, but profit fell 84% sequentially from a strong Q4, indicating a significant margin squeeze.
Borosil Scientific's first-quarter results for FY27 present a mixed picture of growth and pressure. While revenue continued its upward trajectory compared to last year, profitability took a sharp sequential hit, retreating from the exceptional highs of the previous quarter.
The company's revenue for the quarter ended June 2026 stood at ₹106.75 crore, marking a solid 11.2% increase from the same period last year. However, profit after tax (PAT) was ₹4.36 crore, down a steep 84.0% from the ₹27.25 crore earned in Q4 FY26. This dramatic sequential drop pulled the net profit margin down to 4.1%, a significant contraction from the 19.0% margin achieved just three months prior.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 106.75YoY +11% | 143.17 | 95.98 |
| Profit (₹ Cr) | 4.36YoY +204% | 27.25 | -4.21 |
| Net Profit Margin | 4.1%YoY +193% | 19.0% | -4.4% |
The table highlights the volatile profit journey over the past year. The positive year-on-year comparison—turning a ₹4.21 crore loss in Q1 FY26 into a profit—is overshadowed by the sharp quarter-on-quarter decline. This suggests the March quarter may have been an outlier, with performance now settling closer to the levels seen in Q2 and Q3 of last fiscal year.
Key Points
- The trailing twelve-month (TTM) net profit margin stands at 9.0%, indicating the Q1 margin is below the recent average.
- The company maintains a very strong balance sheet, with minimal debt (Debt-to-Equity of 0.04) and a robust interest coverage ratio of 27.13.
- The stock trades at a P/E of 40.5, a modest premium to its industry, reflecting its niche position in laboratory glassware despite the quarterly earnings volatility.
The key question for Borosil Scientific is whether it can stabilize its profitability closer to the TTM average of 9% in the coming quarters, moving past the extreme swings of the last year.
Live Chart
· BOROSCI
(BSE)
ISIN: INE02L001032
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.